InsiderTrades

Form 4 for IRON Disc Medicine, Inc.

Accepted 2025-07-08 00:00:00 ET · period of report 2025-07-03 · accession 0000950170-25-094695 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2025-07-08 2025-07-03 IRON Quisel John D CEO, Dir M - OptEx $9.86 +5,200 167.0K +3% +$51.3K
DT 2025-07-08 2025-07-03 IRON Quisel John D CEO, Dir S - Sale+OE $55.09 -5,200 161.8K -3% -$286.5K
DT 2025-07-08 2025-07-03 IRON Quisel John D CEO, Dir M - OptEx $0.00 -5,200 150.2K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-07-03 M A 5,200 $9.86 167,028 D — —
2 Common Common Stock 2025-07-03 S D 5,200 $55.09 161,828 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
3 Derivative Stock Option (Right to Buy) 2025-07-03 M D 5,200 $0.00 150,175 D $9.86 · — to 2031-09-13 5,200 Common Stock (F3) The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.